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Abstract
Objectives: Hepatic incidentalomas (HI) are asymptomatic lesions detected incidentally during investi-
gations for other pathologies. This prospective series outlines the management and outcomes of 121 HI
managed over 7 years.
Methods: Data were recorded prospectively on 121 patients referred between 2003 and 2010 for
assessment of HI out of 1081 patients referred for a hepatic resection. Patients were reviewed in
multidisciplinary meetings and investigated with tumour markers and radiological investigations. HI were
classified as hypo- or hypervascular depending on arterial phase CT scan findings. Univariate and
multivariate analysis was performed to define predictive factors for malignancy.
Results: Forty HI were hypovascular, 35 were benign (18 cysts, 12 focal fatty sparing, 1 fetal lobulation
and 4 solitary necrotic nodules) and 5 cholangiocarcinomas (all resected)]. Eighty-one HI were hypervas-
cular, 72 were benign [40 focal nodular hyperplasia (FNH), 8 adenoma and 24 hemangiomas) and 9
cancers (5 HCC, 4 metastases: 7 resected). Male gender [relative risk (RR) 2.70, confidence interval (CI)
1.69–3.51], age >45 years (RR 3.15, CI 2.71–3.89), tumour diameter >4 cm (RR 3.35, CI 3.13–4.01) and
late (8 min) enhancement on magnetic resonace imaging (MRI) (RR 4.15, CI 3.01–4.79) were predictive of
malignancy.
Conclusions: HI constitute 10% of practice volume. 10% of hyper and hypovascular incidental lesions
are malignant. Most can be treated aggressively after diagnosis.
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Introduction
Incidentaloma is a term attached to asymptomatic lesions
detected incidentally during investigations for other pathologies.
Most commonly incidentalomas are detected during radiological
investigations although they may also be observed during surgi-
cal procedures such as a laparotomy or laparoscopy. Hepatic
incidentalomas (HI) were first described by Miles Little1 in 1990
and his paper is the first to use the term ‘incidentaloma’.
Hepatic incidentalomas are often detected during ultrasound
investigations for pelvic symptoms or upper abdominal pain.
They are recognized as a modern condition and their investiga-
tion and clinical work up represent a significant work load for
hepatobiliary specialists as hepatic lesions may represent malig-
nant or premalignant lesions. Detection of these lesions at an
early asymptomatic stage may therefore provide an opportunity
to aggressively treat life-threatening conditions while they are
localized, with anticipated improvements in outcome, and with
the potential for intervention with minimally invasive therapies.
However, many HI are benign non-threatening lesions which do
not require intervention, and in which the risks of surgical resec-
tion outweigh the biological risks associated with the lesion.
Consequently, all HI require careful, accurate investigation and
assessment with the aim of establishing a precise diagnosis
without resection.
While a biopsy is a potential tool to establish tissue diagnosis in
HI, the risks of a biopsy in disseminating localized tumours make
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its routine application unsafe and consequently imaging and
serum tumour marker determinations now form the core of the
approach to investigating these lesions.
This investigation describes an approach to the investigation
and management of incidentally detected hepatic lesions present-
ing to a single surgeon between 2003 and 2010.
Methods
The clinical details of patients referred for assessment with inci-
dentally detected solitary liver lesions were recorded prospec-
tively in a computerized database. Patients referred with a
diagnosis of HI were reviewed with a full history and physical
examination with particular emphasis on detection of any signs
of chronic liver disease or malignancy. Blood tests were taken in
all patients including a full blood count, plasma creatinine, urea,
electrolytes and liver function tests. Tumour markers were rou-
tinely checked and included carcinoembryonic antigen (CEA),
Ca 19-9 and a-fetoprotein (AFP). Des gamma carboxy pro-
thrombin or other novel markers of hepatocellular malignancy
were not routinely available and were not utilized in these
patients.
All available radiological investigations were reviewed in a
multidisciplinary meeting. In general, most patients were referred
with an abdominal ultrasound examination and many had an
accompanying computed tomographic (CT) scan at the time of
referral. In the early part of this series, CT scans were generally
ordered if they were not available. However, with the finding on
ultrasound of a solid liver lesions, magnetic resonance imaging
(MRI) became increasingly used as a definitive imaging modality.
Similarly for small hepatic lesions where a cyst was suspected but
could not be confirmed MRI was utilized. After multidisciplinary
review of patients where all available imaging was reviewed along
with available clinical examination findings, tumour marker and
liver function tests, suspected cystic lesions were further investi-
gated with MRI scans while solid lesions were recommended to
undergo either a CT scan or a dedicated MRI scan. A number of
patients were assessed with both imaging techniques. A percuta-
neous biopsy was used, only after extensive discussion, in patients
with suspected disseminated malignant disease to prove the pres-
ence and histotype of malignancy and assist in defining optimal
systemic therapies. The other indication for a biopsy was to prove
the presence of benign disease when this was strongly suspected
after review of all radiological and clinical findings. A biopsy in
this setting was undertaken to definitively prove benign pathology,
reduce patient anxiety and to prevent the requirement for
ongoing radiological imaging. Many patients were reviewed at
several multidisciplinary meetings as their diagnostic work up
progressed.
Cox’s regression analysis was performed to determine the
respective influence of patient and lesion characteristics on
a final malignant diagnosis. A P-value of 0.05 was considered
significant.
Results
Between 2003 and 2010, 121 patients were referred for assessment,
investigation and treatment of incidentally detected liver lesions.
In this period, a total of 1081 patients were referred for hepatic
resection. Of these, 74 (61%) were female and had a median age of
42 years (range 17–74). Of 121 patients, 118 (97.5%) had initially
undergone an abdominal ultrasound examination to investigate
abdominal pain. Three patients presented with incidental liver
lesions initially detected on abdominal CT scans. Two of these
were undertaken in the assessment of a trauma patient after a
motor vehicle accident and another for the assessment of a pos-
sible pelvic mass. The liver lesions were initially investigated with
a CT scan and then classified as hyper- or hypovascular lesions
depending on their arterial phase perfusion. Particular note was
also made of any radiological signs of cirrhosis (ascites, small and
irregular hepatic outline and associated varices).
Overall, patients underwent a median of 3 imaging investiga-
tions (range 1–4), were discussed at 3 multidisciplinary meetings
and work up took between 8 and 47 days (median 22 days).
Hypovascular lesions
Forty patients (33%) presented with hypovascular lesions. The
median age was 54 years (range 43 to 74), 25 were male and 15
female. Nineteen patients had a past history of cancer (14 non-
melanotic skin cancer, thyroid cancer 2, uterine carcinoma 1, cer-
vical carcinoma 1 and laryngeal cancer 1). No patient had
radiological signs of cirrhosis. Thirty-eight patients presented
after ultrasound examination. All 40 patients underwent a triple
phase CT scan and 17 were investigated with MRI.
The final diagnosis of the 40 hypovascular lesions is shown in
Table 1. Twelve patients were found to have areas of focal fatty
sparing in steatotic livers and two of these patients had type 2
diabetes.
Hypervascular lesions
Eighty-one patients (67%, median age 34 years, range 17 to 56)
presented with hypervascular lesions and 58 were female. No
patient had a history of prior cancer but four patients had radio-
logical signs of cirrhosis. All 81 patients presented after an
abdominal ultrasound. The final diagnosis of the 81 hypervascular
lesions is presented in Table 2. On the basis of MRI scanning, 40
were found to be focal nodular hyperplasia with hypervascularity
Table 1 Final diagnosis in 40 patients presenting with hypovascular
incidentalomas
Diagnosis Number Number resected
Total 40 9
Fetal lobulations 1 1 (diagnosisonly)
Focal fatty sparing 12 0
Solitary necrotic nodule 4 4
Cholangiocarcinoma 5 4
Cysts 18 0
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persisting in the hepatobiliary phase after Kupffer cell-specific
contrast (gadobenate dimeglumine, Multihance; Bracco Imaging,
HighWycombe, UK). Five patients were found to have hepatocel-
lular carcinomas (HCC). In all patients there were clinical risk
factors for HCC (heavy alcohol intake in three and one patient
with chronic hepatitis B), although no patients had elevated
serum AFP. These lesions are difficult to differentiate from adeno-
mas but generally brisk enhancement on arterial phase CT scans
with complete washout on venous phase scans was seen. Four
patients were found to have solitary neuroendocrine metastases.
These lesions were hypervascular but all were found to have iden-
tifiable primary tumours in the terminal ileum.
Risk factors for malignancy
Of those lesions found to be malignant, 5 of 40 (12%) were
hypovascular and 9 of 81 (11%) were hypervascular. Male gender
[relative risk (RR) 2.70, confidence interval (CI) 1.69–3.51], age
>45 years (RR 3.15, CI 2.71–3.89), late (8 min) enhancement on
MRI (RR 4.15, CI 3.01–4.79) and tumour diameter >4 cm (RR
3.35, CI 3.13–4.01) were predictive of malignancy (Table 3).
Discussion
This investigation was undertaken to summarize a single sur-
geon’s experience with the investigation and management of inci-
dentally detected lesions of the liver. Incidentalomas are a
significant part of modern hepatobiliary practice with the 121
patients reported in this series presenting over a 7-year period.
This reflects the increasing use and widespread availability of
cross-sectional imaging to investigate abdominal symptoms and
the availability of surgical and ablative techniques to treat hepatic
lesions. Historically many of these lesions probably were present
in the general population but were not detected because of the
lack of available imaging and, when they were, few if any treat-
ment options were available and patients were managed expect-
antly. However, patients with hepatic lesions now require accurate
investigation and diagnosis. Many with incidentally detected
lesions arrive for assessment with high rates of anxiety regarding
possible cancer diagnoses, often primed by referring practitioners,
and many arrive for assessment requesting a hepatic resection or
biopsy. Consequently the ‘test of time’ approach utilized in older
publications on the topic is now unacceptable to most patients.2 It
is possible that this finding may be under-estimated as focal
nodular hyperplasia (FNH) were referred more frequently than
haemangioma raising the possibility than many ‘incidental’ hae-
mangiomas were worked up and diagnosed without specialist
hepatobiliary referral.
Routine biopsy of incidental hepatic lesions is a tempting pros-
pect. However, this investigative technique has a number of pit-
falls. The primary concern with fine needle or core biopsy of
hepatic tumours is a 10–20% risk of needle tract metastases and
tumour dissemination in malignant lesions.3,4 These data are
based on follow-up of patients with colorectal liver metastases
undergoing a biopsy. However, there is reason to suspect that
similar figures would apply to other metastatic adenocarcinomas
and peripheral cholangiocarcinomas. The risk of seeding is less for
hepatocellular carcinoma (HCC) at around 3%.5 A sampling error
and the presence of necrotic material may also compromise the
accuracy of a needle biopsy and false-negative rates of 7–10% have
been recorded.6 Earlier series have concluded that a biopsy is not
helpful in at least 50% of patients, even when it is performed
intra-operatively.2 In comparison, at least in the case of colorectal
liver metastases, cross-sectional imaging has a 99% specificity.3,6
Collectively, these observations have determined that a routine
needle biopsy should not be undertaken in the investigation of HI.
Instead it is utilized in patients with disseminated malignancy,
who are not surgical candidates, to provide a tissue diagnosis and
guide the application of palliative chemotherapy or radiotherapy.
Alternatively it has been used in patients in whom the evidence
points to a benign lesion but in whom a definitive tissue diagnosis
is required or in those patients with truly indeterminate lesions
where cross-sectional imaging has not been able to arrive at a
definitive diagnosis and in whom resectional surgery is high risk
or contraindicated. Typically this is utilized in patients with small
hypervascular lesions where HCC is suspected and serum alpha-
fetoprotein is normal. With a confirmed malignant diagnosis,
these patients may be eligible for listing for a hepatic transplan-
tation, ablative therapy or resection.
A routine hepatic resection has also been undertaken in the
management of HI. The last 10 years of hepatic surgery have been
characterized by numerous reports confirming the safety of HR
and mortality rates of less than 1% are now the norm for most
hepatobiliary units in patients with normal hepatic paren-
chyma.7,8 However, deaths after a resection for benign lesions have
been reported.9 Shimizu et al2 reported on a series of 32 patients
with an incidentally detected presumed malignant tumours
undergoing resection. All patients were found to have a benign
tissue diagnosis. Fifteen patients had a benign tissue diagnosis and
could have been safely observed whereas 17 patients were consid-
ered to have benefited from resection simply because of significant
concerns over a potential malignant diagnosis. Belghiti10 has also
described a series of 51 female patients undergoing resection for
presumed benign lesions. A resection was carried out in all
patients with no serious morbidity and no mortality. Three
Table 2 Final diagnosis in 81 patients presenting with hypervascular
incidentalomas
Diagnosis Number Biopsied Resected Follow-up
Total 81 18 16 16
FNH 40 5 1 26 (6–36 months)
Adenoma 8 8 8
HCC 5 5 5
Haemangioma 24 0 2 0
Neuroendocrine 4 0 3
FNH, focal nodular hyperplasia; HCC, hepatocellular carcinoma.
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patients (6%) had an unexpected final malignant diagnosis (all
small HCC) after presenting with small hypervascular lesions.
Consequently, while routine resection of hepatic incidentalomas
can now be undertaken safely, the majority are benign and a
resection is not indicated and the clinical effort must be directed
at achieving a secure and accurate diagnosis.
Two earlier investigations, both from areas with a high inci-
dence and prevalence of HCC, have attempted to define risk
factors associated with hepatic incidentalomas that make a malig-
nant diagnosis more likely. In Italy, Belli et al11 reported 35 inci-
dentally detected hepatic lesions. Twenty-two proved to be benign
and 13 were HCC. The presence of a risk factor for HCC increased
the chance the hepatic lesion was malignant and patients with
cancers were older than those with benign lesions (65 versus 45
years). Liu et al12 reported 107 incidentally detected hepatic
lesions from Hong Kong. Of these, 62 were malignant after resec-
tion and were made up of 48 HCC, 8 cholangiocarcinoma, 2
lymphoma, 2 cystadenocarcinoma, 1 carcinoid tumour and 1
malignant histiocytoma. On multivariate analysis, male gender,
age greater than 50 years and tumour size greater than 4 cm were
independent predictive factors for malignancy. These investigators
also found low operative mortality and morbidity in patients
undergoing a hepatic resection and found that, of 48 patients with
incidentally detected HCC, survival was significantly better than
patients presenting with symptomatic lesions.
New Zealand does have a high incidence of HCC13 although the
majority of tumours in this series were peripheral cholangiocar-
cinomas or metastatic neuroendocrine tumours. Five HCCs were
also detected. The risk factors for malignancy were similar to those
of Liu et al12 and Belli.11 Older age, larger lesions and male gender
were significant risk factors along with late contrast enhancement
of lesions on MRI. While the majority of HI in this series, as in
others, were young (age35), female and hypervascular, only one
of these proved to be an HCC. Of the remaining tumours, all were
male apart from three patients with neuroendocrine metastases.
Eleven patients were aged 45 years or older with the youngest
patient being a male aged 39 years with an HCC. Four of the five
patients with HCC had radiological signs of cirrhosis whereas no
patient with a benign HI had evidence of cirrhosis. Finally, 12 of
the 14 patients with a malignant diagnosis had tumours 4 cm in
diameter whereas the remaining 2 patients had lesions 3.4 and
3.8 cm in diameter confirming that larger lesions are more likely
to be malignant.
The current investigation has shown that at least 10% of hyper-
vascular lesions and hypovascular lesions presenting incidentally
are malignant indicating that the vascularity per se is not a risk
factor for malignancy. The distinction in vascularity was based on
arterial phase imaging during a CT scan. This proved to be a useful
screening method in defining potential malignant diagnoses and
directing subsequent investigations. This meant that all patients
underwent a CT scan but in practice this proved to be the case. Of
the hypovascular lesions, 18 were found to be simple cysts using a
combination of ultrasound and CT/MRI for small cysts or cysts in
patients with body habitus or position that made imaging with
ultrasound difficult. Twelve patients were proven to have focal
fatty sparing on fat suppressed MRI. While a tissue diagnosis was
not obtained in any of these patients, they have remained well for
at least 2 years after diagnosis making an underlying malignancy
unlikely. Four patients with solitary necrotic nodules were
resected. While this is a benign lesion, we have previously written
about the difficulty in making the diagnosis pre-operatively
and the issues in differentiating these lesions from necrotic
tumours.14,15 Interestingly, Shimizue et al2 reported three patients
in their series who were resected because of ‘encapsulated necrosis’
which probably represent solitary necrotic nodules. In the current
series, five patients were found to have peripheral cholangiocarci-
nomas on the basis of imaging showing an infiltrative, hypovas-
cular tumour and raised plasma Ca19-9 in two patients. One
Table 3 The influence of patient and lesion characteristics on a final malignant diagnosis
Variable Number/number cancers/
total
Univariate Multivariate P-value
Male 9 / 14 / 121 RR 2.67, CI 1.60–3.79 RR 2.70, CI 1.69–3.51 0.046
Female 5 / 14 / 121 RR 1.03, CI 0.96–1.19 RR 1.05, CI 0.96–1.11 NS
Age > 45 years 11 / 14 / 121 RR 3.07, CI 2.63–3.79 RR 3.15, CI 2.71–3.89 < 0.01
Radiological signs of
cirrhosis
4 / 14 / 121 RR 0.87, CI 0.56–0.93 RR 0.93, CI 0.57–0.99 NS
Tumour diameter > 4 cm 12 /14 / 121 RR 3.21, CI 2.77–3.89 RR 3.35, CI 3.13–4.01 < 0.009
Hypovascular 5 / 40 / 121 RR 0.31, CI 0.26–0.73 RR 0.37, CI 0.29–0.86 NS
Hypervascular 9 / 81 / 121 RR 0.44, CI 0.34–0.69 RR 0.47, CI 0.35–0.71 NS
Elevated CEA 0 / 14 / 121 RR 0 RR 0 NS
Late enhancement on MRI 5 / 14 / 121 RR 3.50, CI 2.93–4.40 RR 4.15, CI 3.01–4.79 <0.043
Elevated Ca19-9 2 / 14 / 121 RR 0.39, CI 0.19–0.64 RR 0.44, CI 0.22–0.68 NS
Elevated AFP 2 / 14 / 121 RR 0.37, CI 0.18–0.66 RR 0.39, CI 0.20–0.59 NS
CEA, carcinoembryonic antigen; MRI, magnetic resonace imaging; AFP, a-fetoprotein; RR, relative risk; CI, 95% confidence interval; NS, not
statistically significant.
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patient thought to have a small cholangiocarcinoma was found to
have a small amount of fat in a perisistent fetal lobulation at
laparotomy.
The hypervascular lesions proved to be a more difficult group
of diagnoses. In particular, the differentiation between an
adenoma, well-differentiated HCC and focal nodular hyperplasia
is difficult, particularly for small lesions.10 Five patients with small
hypervascular lesions with complete washout on the portal
venous phase were biopsied on suspicion of being HCC and this
diagnosis was confirmed in all five patients. Two of these patients
had mildly raised, but not diagnostic, alpha fetoprotein levels and
four patients had radiological evidence of cirrhosis. Twenty-four
patients were diagnosed with haemangiomas on CT and MRI
scanning. In two patients the enhancement was atypical and
surgery or a biopsy was recommended. In both patients, a
resection was undertaken confirming the presence of a haeman-
gioma. Eight patients were thought to have adenomas or well-
differentiated HCC. A biopsy confirmed adenomas and all were
resected. Forty patients with hypervascular lesions were diagnosed
with FNH after a dedicatedMRI scan. Of these, five were biopsied,
confirming FNH, because of slightly atypical imaging findings.
One was resected because of the presence of a hypervascular
nodule adjacent and a possible associated HCC. The pathology
confirmed FNH only. Of the 35 FNH and 22 haemangiomas that
were not resected and not biopsied, all have remained well at a
minimum of 2 years of follow-up making an underlying malig-
nant diagnosis unlikely.
This investigation was undertaken to describe one methodol-
ogy developed to manage patients presenting with incidentally
detected liver lesions. This is an increasingly common clinical
problem for hepatobiliary surgeons and reflects the increasing use
and accuracy of cross-sectional imaging techniques and a more
aggressive contemporary stance taken in investigating and treating
hepatic tumours. Overall, HI can constitute 10% of a practice load
and often require multiple radiological investigations and multi-
disciplinary review. However at least 10% of hypovascular and
hypervascular lesions were malignant and can be aggressively
treated.
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